- Exchange: -
- Sector: Consumer, Non-cyclical
- Industry: Biotechnology
- Sub-Industry: Medical-Biomedical/Gene
ARYx Therapeutics Inc
4AX:GR
Ticker Delisted
Snapshot for ARYx Therapeutics Inc (4AX)
| Open: | - | Day's Range: | - | Volume: | 0 |
|---|---|---|---|---|---|
| Previous Close: | - | 52wk Range: | 0.001 - 0.015 | 1-Yr Rtn: | - |
Key Statistics for 4AX
| Current P/E Ratio (ttm) | - |
|---|---|
| Estimated P/E(12/2010) | - |
| Relative P/E vs. DAX | - |
| Earnings Per Share (ttm) | - |
| Est. EPS (12/2010) | - |
| Est. PEG Ratio | - |
| Market Cap (M EUR) | 0.00 |
| Shares Outstanding (M) | 0.00 |
| 30 Day Average Volume | 0 |
| Price/Book (mrq) | - |
| Price/Sale (ttm) | - |
| Dividend Indicated Gross Yield | -% |
| Cash Dividend | - |
| Last Dividend | |
| 5 Year Dividend Growth | - |
| Next Earnings Announcement | - |
mrq = Most Recent Quarter; ttm = Trailing Twelve Months
Income Statement for 4AX
No data available
Company Profile & Key Executives for 4AX
ARYx Therapeutics, Inc. researches and produces anticoagulants, and drugs for treating gastrointestinal disorders and atrial fibrillation.
| Pascal DruzgalaSenior VP/Chf Scientific Ofcr | Daniel M CanafaxVP/Chief Development Officer |
| David NaglerVP:Corporate Affairs/Secretary |
Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.
Sponsored Financial Commentaries
Advertisement
Top Forex Trading Resources
-
4AX News
-
Industry News
No stories found
Advertisement
- 1
- 2
- 3
- 4
- 5
Advertisement
Sponsored Links
Advertisements
Rate this Page